Skip to main content


Cancer results from failures in epigenetic control by chromatin remodelers at the level of gene transcription. The abnormal activation of epithelial to mesenchymal transition (EMT) by carcinomas is an essential hallmark of cancer metastasis that is responsible for more than 90% of cancer deaths.

Our aim is to elucidate the orchestration of EMT-MET cascade by the balancing act of chromatin remodelers and epigenetic modifiers. It is anticipated that chromatin modifying compounds will emerge as the next generation of anticancer therapies.

Find out more


Open to PhD applications in the fields of

  • chromatin remodelers
  • epigenetics
  • cancer metastasis
  • proteomics
  • molecular cell biology
  • biochemistry
Make a PhD enquiry


Research at Queen's

Postgraduate research

Start your application

Apply now
graduate school interior

Postgraduate Experience

The Graduate School

Our dedicated hub for postgraduate students, providing state-of-the-art facilities for study, and high-quality training and development programmes within a diverse interdisciplinary community.

The gateway to your postgraduate experience